Predictive Oncology GAAP EPS of -$0.32, revenue of $0.11M

1 month ago 3

Predictive Oncology press release (NASDAQ:POAI): Q1 GAAP EPS of -$0.32.
Revenue of $0.11M.
The Company recorded revenue of $110,310 for the first quarter of 2025, compared to $4,858 for the comparable period in 2024. The increase in revenue from the comparative period was primarily due to completion of a tumor-specific 3D model in the three months ended March 31, 2025.

Recommended For You